Minneapolis, MN — October 17-19, 2016 

Event: AdvaMed 2016                               


The importance of demonstrating economic outcomes has never been greater for medtech organizations, which translates into a higher-priority focus on their Health Economics and Outcomes Research (HEOR) function. The traditional view of HEOR as a market access function with a longer-term focus on building evidence has evolved. Thanks largely to the shift to value-based care and growing economic demands from provider customers, HEOR is playing an increasingly important role in commercial success. However, many medtech organizations face internal and cultural challenges in optimizing the effectiveness of their HEOR function. These challenges include gaining appropriate mindshare from executive teams that come from a tradition of top-line and sales management; and integrating HEOR across the corporate divide between market access and sales & marketing. Join us for a lively panel discussion that will explore how medtech companies are successfully leveraging and integrating their HEOR functions to achieve commercial impact. L.E.K. Managing Director Ken Graves will moderate this session and panelists include Yvonne Bokelman, Vice President, Global Market Access, Health Economics & Reimbursement, Zimmer Biomet; Nadim Yared, CEO, CVRx, Inc.

Date/Location: October 18, 2016 - Minneapolis Convention Center - Minneapolis, MN

Time: 4:00 — 5:15 pm  

About Kenneth Graves:    

Ken Graves is a Managing Director based in L.E.K. Consulting's Chicago office. He has over 18 years of strategy consulting experience that spans the U.S. and Asia, including nearly 9 years leading L.E.K.'s practice in Japan. He brings broad-based experience in the healthcare industry, collaborating with clients primarily in the medtech, diagnostics, biopharma and service sectors. He advises numerous global healthcare companies on their critical issues, spanning portfolio and business unit growth, country strategies, market access, commercial model optimization, and mergers and acquisitions.

Prior to joining L.E.K. in 2007, Ken was a partner in a U.S.-based strategy consultancy. He received two Bachelor of Science degrees from Oregon State University and a Master of Business Administration from the Kellogg School of Management at Northwestern University.

About AdvaMed 2016

AdvaMed 2016 is the leading MedTech Conference in North America, bringing more than 1,000 companies together in a uniquely multifaceted environment for business development, capital formation, innovative technology showcasing, world-class educational opportunities and networking. An event rich in international flavor and featuring a deep, diverse attendee list that includes influential policy-makers, business executives and media, AdvaMed 2016 seeks to advance industry discussion from key perspectives through detailed panel sessions, executive forums and more. It is a “must-attend” event for any medtech company. Whatever your goals may be, you are sure to accomplish, and even surpass them, at AdvaMed 2016.

About L.E.K. Consulting:

L.E.K. Consulting is a global management consulting firm that uses deep industry expertise and rigorous analysis to help business leaders achieve practical results with real impact. We are uncompromising in our approach to helping clients consistently make better decisions, deliver improved business performance and create greater shareholder returns. The firm advises and supports global companies that are leaders in their industries — including the largest private and public sector organizations, private equity firms and emerging entrepreneurial businesses. Founded more than 30 years ago, L.E.K. employs more than 1,200 professionals across the Americas, Asia-Pacific and Europe. For more information, go to www.lek.com.